Evidence that histamine is the causative toxin of scombroid-fish poisoning. Morrow JD, Margolies GR, Rowland J, Roberts LJ (1991) N Engl J Med 324: 716-20 Increased production of prostaglandin D2 in patients with systemic mastocytosis. Roberts LJ, Sweetman BJ, Lewis RA, Austen KF, Oates JA (1980) N Engl J Med 303: 1400-4 Increased adventitial mast cells in a patient with coronary spasm. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R (1985) N Engl J Med 313: 1138-41 Release of prostaglandin D2 into human airways during acute antigen challenge. Murray JJ, Tonnel AB, Brash AR, Roberts LJ, Gosset P, Workman R, Capron A, Oates JA (1986) N Engl J Med 315: 800-4 Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. Awad JA, Morrow JD, Roberts LJ (1994) J Allergy Clin Immunol 93: 817-24 Intervention with epinephrine in hypotension associated with mastocytosis. Turk J, Oates JA, Roberts LJ (1983) J Allergy Clin Immunol 71: 189-92 Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Liston TE, Roberts LJ (1985) Proc Natl Acad Sci U S A 82: 6030-4 Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. Watanabe K, Iguchi Y, Iguchi S, Arai Y, Hayaishi O, Roberts LJ (1986) Proc Natl Acad Sci U S A 83: 1583-7 Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans. Wendelborn DF, Seibert K, Roberts LJ (1988) Proc Natl Acad Sci U S A 85: 304-8 Hazards in operative management of patients with systemic mastocytosis. Scott HW, Parris WC, Sandidge PC, Oates JA, Roberts LJ (1983) Ann Surg 197: 507-14 Increased formation of thromboxane in vivo in humans with mastocytosis. Morrow JD, Oates JA, Roberts LJ, Zackert WE, Mitchell TA, Lazarus G, Guzzo C (1999) J Invest Dermatol 113: 93-7 Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2. Morrow JD, Guzzo C, Lazarus G, Oates JA, Roberts LJ (1995) J Invest Dermatol 104: 937-40 Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW (2001) Chest 120: 1639-44 New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. Roberts LJ, Salomon RG, Morrow JD, Brame CJ (1999) FASEB J 13: 1157-68 Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. Lewis RA, Holgate ST, Roberts LJ, Maguire JF, Oates JA, Austen KF (1979) J Immunol 123: 1663-8 Effects of prostaglandin D2 on rat serosal mast cells: discordance between immunologic mediator release and cyclic AMP levels. Holgate ST, Lewis RA, Maguire JF, Roberts LJ, Oates JA, Austen KF (1980) J Immunol 125: 1367-73 Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ (1982) J Immunol 129: 1627-31 Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation. Boutaud O, Li J, Zagol I, Shipp EA, Davies SS, Roberts LJ, Oates JA (2003) J Biol Chem 278: 16926-8 Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. Liston TE, Roberts LJ (1985) J Biol Chem 260: 13172-80 Renal response to 9 alpha, 11 beta-prostaglandin F2 in the rat. Stier CT, Roberts LJ, Wong PY (1987) J Pharmacol Exp Ther 243: 487-91 Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay. Morrow JD, Prakash C, Awad JA, Duckworth TA, Zackert WE, Blair IA, Oates JA, Roberts LJ (1991) Anal Biochem 193: 142-8 The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. Kootte AM, Haak A, Roberts LJ (1983) Neth J Med 26: 18-20 Quantification of the PGD2 urinary metabolite 9 alpha-hydroxy-11, 15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid by stable isotope dilution mass spectrometric assay. Roberts LJ (1982) Methods Enzymol 86: 559-70
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.